Clinical Trial Update: Zanubrutinib and Rituximab Followed by R-DHAOx Then Maintenance with Zanubrutinib for Newly-Diagnosed MCL [Phase 2]

View source ↗

Summary

Phase 2 trial investigating zanubrutinib and rituximab followed by R-DHAOx and zanubrutinib maintenance for newly diagnosed mantle cell lymphoma; currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)
• Zanubrutinib (zanubrutinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Mantle Cell Lymphoma, Newly-diagnosed Mantle Cell Lymphoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING